Asset
ONDANSETRON
AQUESTIVE THERAPEUTICS INC. COMMON STOCK
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01220167 | phase1 | completed | 2008-08-01 | 2008-08-01 | Aquestive Therapeutics | Three-way Crossover Study Comparing Ondansetron ODFS Administered With and Without Water to Zofran ODT Without Water |
FDA applications (1)
| Application | Approved | Type | Applicant |
|---|---|---|---|
| NDA 022524 | 2010-07-02 | NDA | AQUESTIVE THERAPEUTICS INC |
Marketed products (2)
- ZUPLENZ
- ZUPLENZ